Ubenimex (bestatin) inhibits invasion and matrilysin activation of human uterine cervical adenocarcinoma OMC-4 cells

International Journal of Gynecological Cancer

Volumn 7, Issue 4, 1997, Pages 289-295

  Masatsugu, U ^a   Minoru, U ^a   Hideji, F ^b   Keiko, Y ^b   Motowo, N ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

^c Takarazuka Research Institute   (Japan)

Author keywords

Aminopeptidase; Bestatin; Invasion; Matrilysin; Uterine cervical adenocarcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINOPEPTIDASE; BESTATIN; CASEIN; DIMETHYL SULFOXIDE; FIBRONECTIN; MATRIGEL; MATRILYSIN;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

EID: 0030685808     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.00456.x     Document Type: Article

References (35)

1. Fidler IJ, Gersten DM, Hart IR. The biology of cancer invasion and metastases. Adv Cancer Res 1978; 28: 149-250.
2. Liotta LA, Rao CV, Barsky SH. Tumor invasion and the extra-cellular matrix. Lab Invest 1983; 49: 636-49.
3. McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT. The role of cell adhesion proteins - laminin and fibronectin - in the movement of malignant and metastatic cells. Cancer Metastasis Rev 1985; 4: 125-52.
4. Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 1987; 47: 1473-87.
5. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1979; 283: 139-46.
6. Werb Z. Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: Saunders, 1989: 300-21.
7. Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
8. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochem Biophysic Acta 1987; 907: 191-217.
9. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-5.
10. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
11. Woessner JF Jr, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1988; 263: 16918-25.
12. Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochem Biophys Acta 1983; 695: 177-214.
13. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A. Expression of MMP-7 (pump-1) mRNA in human colorectal cancers. Int J Cancer 1993; 54: 614-18.
14. Imai K, Yokohama Y, Nakanishi I, et al. Matrix matalloproteinase 7 (matrilysin) from human rectal carcinoma cells. J Biol Chem 1995; 270: 6691-7.
15. Pajouh MS, Nagle RB, Brethnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991; 117: 144-50.
16. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 1995; 83: 298-307.
17. Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot 1976; 29: 97-9.
18. Ota K, Ogawa N. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults. Biomed Pharmacother 1990; 44: 93-102.
19. Blomgren H, Naslund I, Esposti PL, Johansen L, Aaskoven O. Adjuvant bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Cancer Immunol Immunother 1987; 25: 41-6.
20. Saiki I, Murata J, Watanabe K, Fujii H, Abe F, Azuma I. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn J Cancer Res 1989; 80: 873-8.
21. Yoneda J, Saiki I, Fujii H, Abe F, Kojima Y, Azauma I. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin). Clin Exp Metastasis 1992; 10: 49-59.
22. Ueda M, Ueki M, Sugimoto O. Characterization of epidermal growth factor (EGF) receptor and biological effect of EGF on human uterine cervical adenocarcinoma cell line OMC-4. Hum Cell 1993; 6: 218-25.
23. Kihira Y, Mori K, Miyazaki K, Matsuo Y. Production of recombinant human matrix metalloproteinase 7 (matrilysin) with potential role in tumor invasion by refolding from Escherichia coli inclusion bodies and development of sandwich ELISA of MMP-7. Urol Oncol 1996; 2: 20-6.
24. Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991; 40: 118-28.
25. McCarthy JB, Furcht LT. Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol 1984; 98: 1474-80.
26. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
27. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196-202.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
29. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I, Tsuruo T. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD 13. Clin Exp Metastasis 1995; 13: 337-44.
30. Leyhausen G, Schuster DK, Vaith P, et al. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with potential immuno-stimulant and chemotherapeutic agent bestatin. Biochem Pharmacol 1983; 32: 1051-7.
31. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M. Purification and characterization of extracellular-matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal-carcinoma cell line. Cancer Res 1990; 50: 7758-64.
32. Kuramochi H, Motegi A, Iwabuchi M, Takahashi K, Horinishi H, Umezawa H. Action of ubenimex on aminopeptidase activities in spleen cells and peritoneal macrophages from mice. J Antibiot 1987; 40: 1605-11.
33. Amoscato AA, Stamkoski RM, Babcock GF, Alexander JW. Neutral surface aminopeptidase activity of human tumor cell lines. Biochem Biophys Acta 1990; 1041: 317-19.
34. Ashmun RA, Look AT. Metalloproteinase activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 1990; 75: 462-9.
35. Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extra-cellular matrix degradation. Int J Cancer 1993; 54: 137-43.